Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| FDA Issues A Complete Response Letter For Lilly's Olanzapine LAI For Treatment Of Schizophrenia In Adults (Medical News Today) |
 |
 |
|
Eli Lilly and Company (NYSE: LLY) announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults. Lilly is continuing to work with the agency on the new drug application (NDA). |
